Literature DB >> 27605964

Is renal medullary carcinoma the seventh nephropathy in sickle cell disease? A multi-center Nigerian survey.

Madu Anazoeze1, Galadincci Najibah2, Umar Garba3, Abdulahi Shehu4, Fowodu Florence5, Hassan Abdulaziz6, Inyama Marcus7, Akinpelu Oluwaseun8, Nwagha Theresa9, Ibegbulam Obike9, Ocheni Sunday9, Emodi Ifeoma9, Ikefuna Anthony9, Chukwu Barth9, Okocha Chide10, Orkuma Joseph3, Iheanacho Malachy3, Korubo Kaladada11, Anike Uche9, Agu Kingsley9, Nonyelu Charles9, Ugwu Angela9, Duru Augustin9, Anigbo Chikwudi9, Eze Alozie3, Ololo Uchenna9, Omoti Caroline12, Agwu Obineche3, Okpala Iheanyi9.   

Abstract

INTRODUCTION: Previous studies had enlisted renal medullary carcinoma (RMC) as the seventh nephropathy in sickle cell disease (SCD). Clinical experience has contradicted this claim and this study is targeted at refuting or supporting this assumption.
OBJECTIVE: To estimate the prevalence of RMC and describe other renal complications in SCD.
MATERIALS AND METHODS: 14 physicians (haematologists and urologists) in 11 tertiary institutions across the country were collated from patients' case notes and hospital SCD registers.
RESULTS: Of the 3,596 registered sickle patients, 2 (0.056%) had been diagnosed with RMC over a ten year period, thereby giving an estimated prevalence rate of 5.6 per 100,000. The most common renal complication reported by the attending physicians was chronic kidney disease (CKD). The frequency of routine renal screening for SCD patients varied widely between centres - most were done at diagnosis, annually or bi-annually.
CONCLUSION: The ten year prevalence of RMC in Nigerian SCD patients was determined to be 5.6 (estimated incidence of 0.56). RMC is not more common in SCD patients and therefore cannot be regarded as a "Seventh Sickle nephropathy". Most of the managing physicians reported that the commonest nephropathy observed in their SCD patients was chronic kidney disease.

Entities:  

Keywords:  Nigerian survey; Renal medullary carcinoma; seventh nephropathy; sickle cell disease

Mesh:

Year:  2016        PMID: 27605964      PMCID: PMC4994564          DOI: 10.4314/ahs.v16i2.17

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  16 in total

Review 1.  Kidney abnormalities in sickle cell disease.

Authors:  K López Revuelta; M P Ricard Andrés
Journal:  Nefrologia       Date:  2011       Impact factor: 2.033

2.  Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil.

Authors:  Marina Cavalcanti Maroja Silvino; Camila Motta Venchiarutti Moniz; Gustavo Henrique Munhoz Piotto; Sheila Siqueira; Ariel Galapo Kann; Carlos Dzik
Journal:  Rare Tumors       Date:  2013-08-20

Review 3.  Renal medullary carcinoma: a potential sickle cell nephropathy of children and adolescents.

Authors:  W A Wesche; J Wilimas; V Khare; D M Parham
Journal:  Pediatr Pathol Lab Med       Date:  1998 Jan-Feb

4.  Sickle cell nephropathy.

Authors:  L B Berman
Journal:  JAMA       Date:  1974-06-03       Impact factor: 56.272

5.  SMARCB1/INI1 inactivation in renal medullary carcinoma.

Authors:  Julien Calderaro; Julien Moroch; Gaelle Pierron; Florence Pedeutour; Camille Grison; Pascale Maillé; Pascale Soyeux; Alexandre de la Taille; Jérome Couturier; Annick Vieillefond; Marie Christine Rousselet; Olivier Delattre; Yves Allory
Journal:  Histopathology       Date:  2012-06-11       Impact factor: 5.087

6.  Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship.

Authors:  Ruta Gupta; Athanase Billis; Rajal B Shah; Holger Moch; Adeboye O Osunkoya; Wolfram Jochum; Ondrej Hes; Carlos E Bacchi; Marilia G de Castro; Donna E Hansel; Ming Zhou; Mahesha Vankalakunti; Paulo G Salles; Rafael A Cabrera; Allen M Gown; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2012-09       Impact factor: 6.394

Review 7.  Hematuria in sickle cell anemia--not always benign: evidence for excess frequency of sickle cell anemia in African Americans with renal cell carcinoma.

Authors:  B W Baron; R Mick; J M Baron
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

8.  Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation.

Authors:  Qingyan Liu; Susanna Galli; Ramaprasad Srinivasan; William Marston Linehan; Maria Tsokos; Maria J Merino
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

9.  Renal papillary necrosis in sickle cell hemoglobinopathies.

Authors:  K K Pandya; M Koshy; N Brown; D Presman
Journal:  J Urol       Date:  1976-05       Impact factor: 7.450

10.  Renal medullary carcinoma. The seventh sickle cell nephropathy.

Authors:  C J Davis; F K Mostofi; I A Sesterhenn
Journal:  Am J Surg Pathol       Date:  1995-01       Impact factor: 6.394

View more
  2 in total

Review 1.  Renal Medullary Carcinoma: Establishing Standards in Practice.

Authors:  Kathryn E Beckermann; Deva Sharma; Shruti Chaturvedi; Pavlos Msaouel; Miguel R Abboud; Yves Allory; Franck Bourdeaut; Julien Calderaro; Aguirre A de Cubas; Vimal K Derebail; Andrew L Hong; Rakhi P Naik; Gabriel G Malouf; Elizabeth A Mullen; Victor E Reuter; Charles W M Roberts; Cheryl L Walker; Christopher G Wood; Michael R DeBaun; Hendrik Van Poppel; Nizar M Tannir; W Kimryn Rathmell
Journal:  J Oncol Pract       Date:  2017-07       Impact factor: 3.840

2.  Sarcomatoid Renal Cell Carcinoma in an Adolescent with Sickle Cell Anaemia.

Authors:  H R Ahmad; J A Faruk; M A Bugaje; A Solomon; M O A Samaila; R M Akuse
Journal:  Case Rep Oncol Med       Date:  2017-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.